2010
DOI: 10.2147/dmso.s7005
|View full text |Cite
|
Sign up to set email alerts
|

The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
34
1
6

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 114 publications
(43 citation statements)
references
References 167 publications
(211 reference statements)
2
34
1
6
Order By: Relevance
“…The inhibitory effect of serum TG elevation may be related to the regulation of intestinal uptake, due in part to the inhibition of TG digestion and/or its absorption mediated by pancreatic lipase, that hydrolyzes dietary triglycerides to mono-and diglycerides and fatty acids which are absorbed by the enterocytes (Tucci et al, 2010). Therefore, the in vitro inhibitory capacity of pancreatic lipase by herbal infusions was tested (Fig.…”
Section: Oral Lipid Tolerance Testmentioning
confidence: 99%
“…The inhibitory effect of serum TG elevation may be related to the regulation of intestinal uptake, due in part to the inhibition of TG digestion and/or its absorption mediated by pancreatic lipase, that hydrolyzes dietary triglycerides to mono-and diglycerides and fatty acids which are absorbed by the enterocytes (Tucci et al, 2010). Therefore, the in vitro inhibitory capacity of pancreatic lipase by herbal infusions was tested (Fig.…”
Section: Oral Lipid Tolerance Testmentioning
confidence: 99%
“…It was announced that Cetilistat was moving into Phase III clinical trials for the treatment of obesity. The success of lipase inhibitors has driven investigations into new generations of nutraceuticals, dietary supplements and pharmaceutical agents that inhibit the breakdown of fats and complex carbohydrates within the gastrointestinal tract (9,10). Lipase inhibitors may soon be used for other pharmaceutical applications, such as the treatment of type 2 diabetes (11,12), atherosclerosis (13), tuberculosis (14)(15)(16), and probably cancer, since Orlistat was also found to have anti-tumoral effects via its inhibitory action on fatty acid synthase (17).…”
Section: Introductionmentioning
confidence: 99%
“…4) which leads to decreased uptake of dietary carbohydrates that suppress postprandial hyperglycemia without increasing insulin level, which is useful to treat diabetic and/or obese patients [59]. Continuous blockade of enzyme by these "starch blockers" results in simultaneous reduction in body weight, HbA1c level and serum triglyceride [60].…”
Section: Chalcones As A-glucosidase Inhibitorsmentioning
confidence: 99%